Form 4: IFF Executive Angela Strzelecki Reports Stock Transactions
SEC Form 4 Filing
Angela Strzelecki, President of Pharma Solutions at International Flavors & Fragrances Inc. (IFF), reports acquisition and disposal of common stock related to a long-term incentive plan.
Summary
- On March 4, 2025, Angela Strzelecki, President of Pharma Solutions at International Flavors & Fragrances Inc. (IFF), reported transactions involving IFF common stock.
- Strzelecki acquired 96 shares of common stock as part of the 2022-2024 Long Term Incentive Plan (LTIP) cycle, with the share price determined based on the average closing market price prior to January 1, 2022.
- Concurrently, 34 shares were disposed of to satisfy tax withholding obligations related to the LTIP share receipt, at a price of $79.79 per share.
- Following these transactions, Strzelecki beneficially owns 8,601 shares of IFF common stock directly.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It reflects routine transactions related to executive compensation and tax obligations. There's no indication of unusual activity or concern.
Positives
- The acquisition of shares through the LTIP indicates a vested interest in the company's long-term performance.
Negatives
- The disposal of shares to cover tax obligations, while standard, slightly reduces the executive's holdings.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they are related to executive compensation and tax obligations.
Key Dates
| Date | Description |
|---|---|
| January 1, 2022 | First stock trading day of the 2022-2024 Long Term Incentive Plan (LTIP) cycle; used to determine share price for LTIP payout. |
| 03/04/2025 | Date of the reported stock acquisition and disposal transactions. |
| 03/06/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.